Show simple item record

dc.contributor.authorHattersley, Andrew T.en
dc.contributor.authorThorens, B.en
dc.date.accessioned2016-08-09T14:36:03Z
dc.date.available2016-08-09T14:36:03Z
dc.date.issued2015-09-03
dc.identifier.citationType 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion. 2015, 373 (10):974-6 N. Engl. J. Med.en
dc.identifier.issn1533-4406
dc.identifier.pmid26332554
dc.identifier.doi10.1056/NEJMcibr1506573
dc.identifier.urihttp://hdl.handle.net/11287/618135
dc.language.isoenen
dc.publisherNEJMen
dc.relation.urlhttp://www.nejm.org/doi/abs/10.1056/NEJMcibr1506573?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmeden
dc.rightsArchived with thanks to The New England journal of medicineen
dc.subjectWessex Classification Subject Headings::Endocrinology::Diabetesen
dc.subjectWessex Classification Subject Headings::Oncology. Pathology.::Geneticsen
dc.titleType 2 Diabetes, SGLT2 Inhibitors, and Glucose Secretion.en
dc.typeJournal Articleen
dc.identifier.journalThe New England Journal of Medicineen
dc.type.versionPublisheden


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record